Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

KRX-0401 Perifosine

Drug (Brand/Generic)

KRX-0401 (perifosine)

Company/Licensee

Keryx Biopharmaceuticals

Therapy Class

Oral inhibitor

Product Description

Anti-cancer agent that inhibits Akt

Current Indication

Extending time to progression and improving overall response of refractory multiple myeloma

Market Sector

Multiple myeloma

Development Status

Phase III for multiple myeloma and refractory advanced colorectal cancer
Expand

Go Top